Dr. Inder K. Daftari obtained a Master’s degree in Physics from Roorkee University, Roorkee, India, in 1969. He subsequently pursued a Doctorate in High Energy Physics from Jadavpur University, Calcutta, India, in 1974. In 1981, Dr. Daftari joined the Experimental High-Energy Physics (Antiproton Group) at Syracuse University, in Syracuse, New York, where he engaged in research projects on antiproton annihilations at Brookhaven National Laboratory, New York. Following his training in Medical Physics at Thomas Jefferson University, Philadelphia, Pennsylvania, Dr. Daftari joined the Research Medicine Department at Lawrence Berkeley National Laboratory in 1986. During this tenure, he focused on developing heavy charged particle treatments for cancer patients. Since 1994, Dr. Daftari has been working at the University of California, San Francisco (UCSF) to provide proton-beam therapy to ocular melanoma patients. His research interests encompass both conventional and unconventional approaches.
Dr. Inder K. Daftari obtained a Master’s degree in Physics from Roorkee University, Roorkee, India, in 1969. He subsequently pursued a Doctorate in High Energy Physics from Jadavpur University, Calcutta, India, in 1974. In 1981, Dr. Daftari joined the Experimental High-Energy Physics (Antiproton Group) at Syracuse University, in Syracuse, New York, where he engaged in research projects on antiproton annihilations at Brookhaven National Laboratory, New York. Following his training in Medical Physics at Thomas Jefferson University, Philadelphia, Pennsylvania, Dr. Daftari joined the Research Medicine Department at Lawrence Berkeley National Laboratory in 1986. During this tenure, he focused on developing heavy charged particle treatments for cancer patients. Since 1994, Dr. Daftari has been working at the University of California, San Francisco (UCSF) to provide proton-beam therapy to ocular melanoma patients. His research interests encompass both conventional and unconventional approaches.